Medical Hypotheses
Volume 67, Issue 3 , Pages 488-492, 2006

Dose effects in gene environment interaction: An enzyme kinetics based approach

  • Seymour Garte

      Affiliations

    • Corresponding Author InformationTel.: +1 412 623 2015; fax: +1 412 623 3878.

Molecular Carcinogenesis Program, University of Pittsburgh Cancer Institute, Hillman Cancer Center, 5150 Center Av Suite 1A, Pittsburgh, PA 15232, United States

Received 8 March 2006; accepted 13 March 2006. published online 04 May 2006.

Summary 

There have been many observations of different forms of the effect of dose in toxicological and pharmacological research into gene environment interactions. In one form, the effect of genetic variation is seen to be more potent at lower doses, while in the other, the genetic variant has a stronger effect at higher doses of exposure. The application of principles of classical enzyme kinetics to this problem has led to a hypothesis that for any gain of function polymorphism, a low exposure gene (LEG) or low dose effect will always be observed, while for any loss of function polymorphism, the high exposure gene (HEG) effect will always be seen. Furthermore the dose effect is found to be independent of any effects on Vmax, but is related to effects on Km of the gene product. The hypothesis is derived from the Michaelis–Menten equation, and if supported by experimental evidence, could lead to important implications for drug dosage and toxicological risk analysis in the context of individual differences in genetic profiles.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0306-9877(06)00200-3

doi:10.1016/j.mehy.2006.03.018

Medical Hypotheses
Volume 67, Issue 3 , Pages 488-492, 2006